Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2017

Jan 4, 2017

31949_dirs_2017-01-04_d60b2d5a-0867-4292-848e-3e4a3ee2103d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-01-03

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-03 Ordinary Shares J 2242664 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 19136038 Indirect
Ordinary Shares 84699 Direct

Footnotes

F1: On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares.

F2: Mr. Doyle is a managing director of WFD Ventures LLC, which is the managing member of WFD Ventures Fund A, LLC. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

F3: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.